Skip to main content

Publisher: Elsevier

Volume 32, Number 9, September 1997

Cardiac ischaemia: possibilities for future drug therapy
pp. 687-707(21)
Authors: Chatelain, P.; Massingham, R.

Favourites:
ADD

Configurationally stable analogs of styrylxanthines as A2A adenosine receptor antagonists
pp. 709-719(11)
Authors: Muller, C.; Schobert, U.; Hipp, J.; Geis, U.; Frobenius, W.; Pawlowski, M.

Favourites:
ADD

Reversible inhibition of type B monoamine oxidase. Theoretical study of model diazo heterocylic compounds
pp. 721-730(10)
Authors: Wouters, J.; Ooms, F.; Jegham, S.; Koenig, J.; George, P.; Durant, F.

Favourites:
ADD

Synthesis of arylpiperazines with a terminal naphthothiazole group and their evaluation on 5-HT, DA and α receptors
pp. 739-746(8)
Authors: Perrone, R.; Berardi, F.; Colabufo, N.; Tortorella, V.; Fornaretto, M.; Caccia, C.; McArthur, R.

Favourites:
ADD

Radiosynthesis of [tetrazoyl-11C]irbesartan, a non-peptidic angiotensin II antagonist
pp. 747-752(6)
Authors: Ponchant, M.; demphel, S.; Hinnen, F.; Crouzel, C.

Favourites:
ADD
Favourites:
ADD

Synthesis and antimicrobial activity of rhodanine derivatives
pp. 759-762(4)
Authors: Habib, N.; Rida, S.; Badawey, E.; Fahmy, H.; Ghozlan, H.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more